Indemnification Agreements
Pharmaceuticals
Pharmaceuticals (338) | Indemnification Agreements (8,213)
- ACELRX PHARMACEUTICALS INC (1 contract)
- Acer Therapeutics Inc. (5)
- ADIAL PHARMACEUTICALS, INC. (1)
- Aegerion Pharmaceuticals, Inc. (3)
- AEON Biopharma, Inc. (1)
- AERIE PHARMACEUTICALS INC (1)
- Aerpio Pharmaceuticals, Inc. (2)
- AGILE THERAPEUTICS INC (2)
- ALIMERA SCIENCES INC (1)
- Allergan, plc (4)
- Altus Pharmaceuticals Inc. (1)
- Amphastar Pharma (1)
- Ampio Pharmaceuticals, Inc. (2)
- Amylyx Pharmaceuticals, Inc. (2)
- Anebulo Pharmaceuticals, Inc. (1)
- Angion Biomedica Corp. (2)
- ANGIOTECH PHARMACEUTICALS INC (7)
- Applied BioSciences Corp. (6)
- APRICUS BIOSCIENCES, INC. (1)
- Aquestive Therapeutics, Inc. (1)
- ARTELO BIOSCIENCES, INC. (4)
- Artemis Therapeutics, Inc. (2)
- ARVINAS, INC. (1)
- ATAI Life Sciences B.V. (1)
- Atea Pharmaceuticals, Inc. (1)
- Athira Pharma, Inc. (1)
- Auspex Pharmaceuticals, Inc. (1)
- AVANIR PHARMACEUTICALS, INC. (2)
- AVENUE THERAPEUTICS, INC. (1)
- AYTU BIOSCIENCE, INC (4)
- Bakhu Holdings, Corp. (2)
- Big Rock Partners Acquisition Corp. (1)
- BIODELIVERY SCIENCES INTERNATIONAL INC (2)
- BioNumerik Pharmaceuticals, Inc. (1)
- BioPharmX Corp (2)
- Blue Water Acquisition Corp. (2)
- Cancer Prevention Pharmaceuticals, Inc. (1)
- Cara Therapeutics, Inc. (1)
- CARDAX, INC. (1)
- CASSAVA SCIENCES INC (1)
- Cerecor Inc. (2)
- CHIASMA, INC (1)
- CinCor Pharma, Inc. (1)
- Cingulate Inc. (1)
- Clearside Biomedical, Inc. (1)
- CLS Holdings USA, Inc. (3)
- Cocrystal Pharma, Inc. (2)
- COGNITION THERAPEUTICS INC (1)
- COLLEGIUM PHARMACEUTICAL, INC (1)
- CoLucid Pharmaceuticals, Inc. (1)
- Context Therapeutics Inc. (1)
- Corcept Therapeutics Incorporated (1)
- CorMedix Inc. (2)
- CUMBERLAND PHARMACEUTICALS INC (1)
- Cyteir Therapeutics, Inc. (1)
- Dermata Therapeutics, Inc. (1)
- DiCE MOLECULES HOLDINGS, LLC (1)
- Dova Pharmaceuticals Inc. (1)
- Edgewise Therapeutics, Inc. (1)
- Egalet Corp (1)
- Elixir Pharmaceuticals, Inc. (1)
- Eloxx Pharmaceuticals, Inc. (11)
- Endo International plc (2)
- Evofem Biosciences, Inc. (2)
- Evoke Pharma Inc (1)
- Evolus, Inc. (1)
- Exactus, Inc. (1)
- EyePoint Pharmaceuticals, Inc. (4)
- Fulcrum Therapeutics, Inc. (1)
- GB SCIENCES INC (5)
- GRAYBUG VISION, INC. (1)
- Green Thumb Industries Inc. (2)
- GridIron BioNutrients, Inc. (3)
- Harmony Biosciences Holdings, Inc. (1)
- Haymaker Acquisition Corp. III (1)
- Horizon Pharma plc (3)
- Ikena Oncology, Inc. (1)
- IMARA Inc. (3)
- Innoviva, Inc. (3)
- Intra-Cellular Therapies, Inc. (1)
- ISTA PHARMACEUTICALS INC (1)
- Jaguar Health, Inc. (1)
- JAVELIN PHARMACEUTICALS, INC (2)
- Jazz Pharmaceuticals plc (3)
- Journey Medical Corp (1)
- Jushi Holdings Inc. (1)
- Kala Pharmaceuticals, Inc. (1)
- Kaleido Biosciences, Inc. (2)
- KOLLTAN PHARMACEUTICALS INC (1)
- Landos Biopharma, Inc. (1)
- LIPELLA PHARMACEUTICALS INC (1)
- Lipocine Inc. (1)
- Liquidia Corp (1)
- Longboard Pharmaceuticals, Inc. (1)
- Lyra Therapeutics, Inc. (1)
- Mallinckrodt (5)
- MAP Pharmaceuticals, Inc. (1)
- MARINUS PHARMACEUTICALS INC (6)
- Medicine Man Technologies, Inc. (1)
- MedMen Enterprises, Inc. (1)
- Menlo Therapeutics Inc. (2)
- MiddleBrook Pharmaceuticals, Inc. (1)
- Mylan N.V. (1)
- MYnd Analytics, Inc. (2)
- MyoKardia Inc (1)
- Neos Therapeutics, Inc. (1)
- Neuralstem, Inc. (1)
- NewBridge Global Ventures, Inc. (1)
- NGM BIOPHARMACEUTICALS INC (1)
- Novan, Inc. (2)
- OCULAR THERAPEUTIX, INC (1)
- Odonate Therapeutics, Inc. (1)
- Omthera Pharmaceuticals, Inc. (1)
- OncoMed Pharmaceuticals Inc (1)
- OptiNose, Inc. (12)
- ORAMED PHARMACEUTICALS INC. (11)
- OTONOMY, INC. (1)
- Pacira Pharmaceuticals, Inc. (1)
- PANACOS PHARMACEUTICALS, INC. (1)
- Paratek Pharmaceuticals, Inc. (5)
- PaxMedica, Inc. (1)
- Phathom Pharmaceuticals, Inc. (1)
- PLIANT THERAPEUTICS, INC. (1)
- PLx Pharma Inc. (3)
- PONIARD PHARMACEUTICALS, INC. (2)
- PREDIX PHARMACEUTICALS HOLDINGS INC (1)
- Prestige Brands Holdings Inc (2)
- PRESTWICK PHARMACEUTICALS INC (1)
- PROVECTUS BIOPHARMACEUTICALS, INC. (5)
- Provention Bio, Inc. (1)
- QUATRX PHARMACEUTICALS CO (1)
- Ra Pharmaceuticals, Inc. (1)
- Rain Therapeutics Inc. (1)
- Rani Therapeutics Holdings, Inc. (1)
- REATA PHARMACEUTICALS INC (12)
- RELMADA THERAPEUTICS, INC. (3)
- resTORbio, Inc. (4)
- Rib-X Pharmaceuticals, Inc. (1)
- SANCILIO PHARMACEUTICALS COMPANY, INC. (1)
- Satsuma Pharmaceuticals, Inc. (1)
- Scopus BioPharma Inc. (1)
- scPharmaceuticals Inc. (1)
- SenesTech, Inc. (1)
- Sienna Biopharmaceuticals, Inc. (1)
- Strongbridge Biopharma plc (1)
- Sucampo Pharmaceuticals, Inc. (11)
- Supernus Pharmaceuticals, Inc. (1)
- Tarsus Pharmaceuticals, Inc. (1)
- Tenzing Acquisition Corp. (2)
- Terns Pharmaceuticals, Inc. (1)
- Terra Tech Corp. (12)
- TETRALOGIC PHARMACEUTICALS CORP (2)
- TETRAPHASE PHARMACEUTICALS INC (4)
- TEVA PHARMACEUTICAL INDUSTRIES LTD (1)
- TherapeuticsMD, Inc. (1)
- Theseus Pharmaceuticals, Inc. (1)
- Tilray, Inc. (1)
- TITAN PHARMACEUTICALS INC (1)
- Trevi Therapeutics, Inc. (1)
- Tricida, Inc. (1)
- Upjohn Inc (1)
- Urovant Sciences Ltd. (2)
- Vallon Pharmaceuticals, Inc. (1)
- Ventyx Biosciences, Inc. (1)
- Verrica Pharmaceuticals Inc. (1)
- VIA Pharmaceuticals, Inc. (1)
- Viamet Pharmaceuticals Holdings LLC (1)
- Virpax Pharmaceuticals, Inc. (1)
- Vitality Biopharma, Inc. (1)
- VIVUS INC (1)
- Vyrix Pharmaceuticals, Inc. (1)
- XERIS PHARMACEUTICALS INC (2)
- Zoetis (1)
- ZOGENIX, INC. (1)
- Zynerba Pharmaceuticals, Inc. (1)
- Form of Indemnification Agreement between the Company and each of its directions and officers (Angion Biomedica Corp., Filed With SEC on June 2, 2023)
- Form of Indemnification Agreement between the Company and each of its directors and executive officers (CorMedix Inc., Filed With SEC on May 15, 2023)
- Form of Indemnification Agreement (Vallon Pharmaceuticals, Inc., Filed With SEC on April 21, 2023)
- Form of Amended and Restated Indemnification Agreement (Non-VC Directors) (MARINUS PHARMACEUTICALS INC, Filed With SEC on March 9, 2023)
- Form of Indemnification Agreement (OptiNose, Inc., Filed With SEC on March 7, 2023)
- Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers (ORAMED PHARMACEUTICALS INC., Filed With SEC on March 6, 2023)
- Form of Indemnification Agreement of the Company (IMARA Inc., Filed With SEC on March 1, 2023)
- Form of Indemnification Agreement for Lipella Pharmaceuticals Inc (LIPELLA PHARMACEUTICALS INC, Filed With SEC on November 28, 2022)
- Form of Indemnification Agreement (Artemis Therapeutics, Inc., Filed With SEC on November 21, 2022)
- Form of Indemnification Agreement, dated May 20, 2022, by and between Mission Holdings US, Inc. and Director (Medicine Man Technologies, Inc., Filed With SEC on November 10, 2022)
- Form of Indemnification Agreement (OptiNose, Inc., Filed With SEC on November 10, 2022)
- Form of Indemnification Agreement (Artemis Therapeutics, Inc., Filed With SEC on September 21, 2022)
- Form of Indemnification Agreement (OptiNose, Inc., Filed With SEC on August 11, 2022)
- Indemnification Agreement by and between the Company and Steven W. Ryder, dated as of July 11, 2022. (incorporated by reference to Exhibit 10.2 to the Companys Form 8-K (File No.... (REATA PHARMACEUTICALS INC, Filed With SEC on August 8, 2022)
- BAKHU HOLDINGS, CORP. INDEMNIFICATION AGREEMENT (Bakhu Holdings, Corp., Filed With SEC on August 4, 2022)
- Form of Indemnification Agreement, by and between Jushi Holdings Inc. and each of its directors and executive officers (Jushi Holdings Inc., Filed With SEC on July 22, 2022)
- Indemnification Agreement by and between the Company and Steven W. Ryder, dated as of July 11, 2022 (REATA PHARMACEUTICALS INC, Filed With SEC on July 12, 2022)
- Form of Indemnification Agreement (AYTU BIOSCIENCE, INC, Filed With SEC on July 1, 2022)
- Form of Indemnification Agreement (Haymaker Acquisition Corp. III, Filed With SEC on June 2, 2022)
- Form of Indemnification Agreement (OptiNose, Inc., Filed With SEC on May 12, 2022)
- Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers (ORAMED PHARMACEUTICALS INC., Filed With SEC on May 12, 2022)
- Form of Indemnification Agreement between Ampio Pharmaceuticals, Inc. and certain directors, executive officers and key employees (Ampio Pharmaceuticals, Inc., Filed With SEC on March 29, 2022)
- Form of Amended and Restated Indemnification Agreement (Non-VC Directors) (MARINUS PHARMACEUTICALS INC, Filed With SEC on March 24, 2022)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (resTORbio, Inc., Filed With SEC on March 15, 2022)
- Form of Indemnification Agreement between EyePoint Pharmaceuticals, Inc. and its officers and directors (EyePoint Pharmaceuticals, Inc., Filed With SEC on March 14, 2022)
- Form of Indemnification Agreement (OptiNose, Inc., Filed With SEC on March 8, 2022)
- Form of Indemnification Agreement between Registrant and each of its directors and officers (CASSAVA SCIENCES INC, Filed With SEC on March 1, 2022)
- INDEMNIFICATION AGREEMENT (Green Thumb Industries Inc., Filed With SEC on March 1, 2022)
- Indemnification Agreement by and between the Company and Samina Khan, dated as of February 24, 2020 (REATA PHARMACEUTICALS INC, Filed With SEC on February 28, 2022)
- Indemnification Agreement by and between the Company and Andrea Loewen, dated as of February 24, 2020 (REATA PHARMACEUTICALS INC, Filed With SEC on February 28, 2022)
- Form of Indemnification Agreement with Executive Officers and Directors (CinCor Pharma, Inc., Filed With SEC on December 17, 2021)
- Form of Director Indemnification Agreement (Amylyx Pharmaceuticals, Inc., Filed With SEC on December 16, 2021)
- Form of Officer Indemnification Agreement (Amylyx Pharmaceuticals, Inc., Filed With SEC on December 16, 2021)
- Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers (ORAMED PHARMACEUTICALS INC., Filed With SEC on November 24, 2021)
- Form of Indemnification Agreement between Journey Medical Corporation and each director (Journey Medical Corp, Filed With SEC on October 22, 2021)
- Form of Indemnification Agreement between the Registrant and its directors and officers (AEON Biopharma, Inc., Filed With SEC on October 4, 2021)
- Form of Indemnification Agreement (Theseus Pharmaceuticals, Inc., Filed With SEC on September 30, 2021)
- Indemnification Agreement, dated as of September 26, 2021 (Scopus BioPharma Inc., Filed With SEC on September 30, 2021)
- Form of Indemnification Agreement (Ventyx Biosciences, Inc., Filed With SEC on September 29, 2021)
- Form of Indemnification Agreement for Officers and Directors (MedMen Enterprises, Inc., Filed With SEC on September 24, 2021)
